Press Releases July 16, 2026 04:05 PM

iRhythm Holdings to Report Second Quarter 2026 Financial Results on August 6, 2026

iRhythm Holdings schedules Q2 2026 earnings release and conference call for August 6, 2026

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
IRTC

iRhythm Holdings, a digital health care company specializing in wearable biosensors and cloud data analytics for disease detection and prevention, announced it will report its second quarter 2026 financial results after market close on August 6, 2026. A management conference call and webcast will follow to discuss the results.

iRhythm Holdings to Report Second Quarter 2026 Financial Results on August 6, 2026
IRTC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • iRhythm Holdings will release its Q2 2026 financial results on August 6, 2026 after market close.
  • The company develops wearable biosensors and cloud-based analytics focused on heart disease detection and prevention.
  • A live webcast and conference call will be available to investors and interested parties to discuss the quarter's results.

SAN FRANCISCO, July 16, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it will release financial results for the second quarter 2026 after the close of trading on Thursday, August 6, 2026. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.

Interested parties may access a live and archived webcast of the conference call on the “Quarterly Results” section of the company’s investor website at investors.irhythmtech.com.

About iRhythm Holdings, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.

Investor Contact
[email protected]

Media Contact
Kassandra Perry
[email protected]


Risks

  • The earnings report could reflect lower than expected financial or operational performance.
  • Market uncertainty about adoption rates or competitive developments in digital health care wearables.
  • Potential regulatory or reimbursement challenges that impact the company's growth or profitability.

More from Press Releases

Acoramidis Demonstrates Reversal of Cardiac Structural Disease Progression and Functional Decline and Significantly Increases Days Alive and Free from Hospitalization in ATTR-CM Aug 30, 2026 Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026 Aug 29, 2026 Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 Aug 29, 2026 20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity Aug 28, 2026 Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update Aug 28, 2026